Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advanced Neuromodulation Systems CE-marks Genesis IPG (implantable pulse generator) system:

This article was originally published in Clinica

Executive Summary

Advanced Neuromodulation Systems has CE-marked for sale in Europe its Genesis totally implantable pulse generator spinal cord stimulator for pain relief. The Plano, Texas-based company says a decision is expected imminently from the US FDA as to whether the product can be reclassified as a class II device (from class III). The reclassification will allow ANS to submit the device to the FDA via the 510(k) marketing clearance process rather than the PMA route, which usually involves a longer procedure.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT069495

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel